The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

International Biobanking for Lung Cancer and COPD as the Future Resource for Clinical Protein Research

På svenska

Author

Summary, in English

Characterized tissue with pathological grading and blood samples as well as other biofluids forms the basis for all biobanks as a resource in modern life science. Biobanks are accessed to measure biological components that can be used to monitor the status of health and disease in individual samples and population groups. The biomarker diagnostics area, predicting drug efficacy, stratification of patient groups, can benefit from the continuous qualitative developments, where Proteomics can make a difference in lung cancer and COPD. This in turn can provide key treasures to novel drugs for personalized medicine in the future.

Publishing year

2013

Language

English

Pages

3-7

Publication/Series

EuPA Open Proteomics

Volume

1

Document type

Journal article

Publisher

Elsevier

Topic

  • Medical Engineering

Keywords

  • Lung Cancer
  • COPD
  • Biobank
  • Pathology

Status

Published

ISBN/ISSN/Other

  • ISSN: 2212-9685